0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Breast Cancer
 41-60 of 767 Articles
JAMA Oncology | 
Editorial |  ONLINE FIRST
Mark D. Pegram, MD
JAMA Oncol. Published online April 14, 2016. doi:10.1001/jamaoncol.2016.0238

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Ahmad Awada, MD, PhD; Ramon Colomer, MD, PhD; Kenichi Inoue, MD; et al.
JAMA Oncol. Published online April 14, 2016. doi:10.1001/jamaoncol.2016.0237
Includes: Supplemental Content

JAMA Neurology | 
Original Investigation | 
Thaís Armangué, MD, PhD; Lidia Sabater, PhD; Estefanía Torres-Vega, BSc; et al.
JAMA Neurol. 2016;73(4):417-424. doi:10.1001/jamaneurol.2015.4607.
Includes: Supplemental Content

JAMA Oncology | 
Invited Commentary | 
Monica Morrow, MD
JAMA Oncol. 2016;2(4):516-517. doi:10.1001/jamaoncol.2015.4919.

JAMA Oncology | 
Original Investigation | 
Sarah S. Mougalian, MD; Mike Hernandez, MS; Xiudong Lei, PhD; et al.
JAMA Oncol. 2016;2(4):508-516. doi:10.1001/jamaoncol.2015.4935.
Includes: Supplemental Content

JAMA Oncology | 
From The JAMA Network | 
Franco Berrino, MD
JAMA Oncol. 2016;2(4):535-536. doi:10.1001/jamaoncol.2015.5679.

JAMA Oncology | 
Research Letter | 
Firas Abdollah, MD; Maxine Sun, MPH; Jesse D. Sammon, DO; et al.
JAMA Oncol. 2016;2(4):543-545. doi:10.1001/jamaoncol.2015.5871.

JAMA Oncology | 
Viewpoint | 
Caroline Wilson, MRCP, PhD; Robert Coleman, MD, FRCP
JAMA Oncol. 2016;2(4):423-424. doi:10.1001/jamaoncol.2015.5768.

JAMA Oncology | 
Editorial | 
Ethan Basch, MD
JAMA Oncol. 2016;2(4):433-434. doi:10.1001/jamaoncol.2015.4719.

JAMA Oncology | 
Original Investigation | 
Filippo Montemurro, MD; Gloria Mittica, MD; Celeste Cagnazzo, PhD; et al.
JAMA Oncol. 2016;2(4):445-452. doi:10.1001/jamaoncol.2015.4720.
Includes: Supplemental Content

JAMA Surgery | 
Research Letter | 
Katharine Yao, MD; Jeff Belkora, PhD; Mark Sisco, MD; et al.
JAMA Surg. 2016;151(4):391-393. doi:10.1001/jamasurg.2015.3601.

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Catherine R. Marinac, BA; Sandahl H. Nelson, MS; Caitlin I. Breen, BS, BA; et al.
JAMA Oncol. Published online March 31, 2016. doi:10.1001/jamaoncol.2016.0164

JAMA Oncology | 
Original Investigation |  Open Access ONLINE FIRST
Amy Ming-Fang Yen, PhD; Huei-Shian Tsau, PhD; Jean Ching-Yuan Fann, PhD; et al.
JAMA Oncol. Published online March 31, 2016. doi:10.1001/jamaoncol.2016.0447
Includes: Supplemental Content

JAMA | 
JAMA Diagnostic Test Interpretation | 
Talal Hilal, MD; Edward H. Romond, MD
JAMA. 2016;315(12):1280-1281. doi:10.1001/jama.2015.17463.

JAMA | 
Medical News & Perspectives | 
Julie A. Jacob, MA
JAMA. 2016;315(12):1217-1218. doi:10.1001/jama.2016.0510.

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Elizabeth A. Mittendorf, MD, PhD; Jose Vila, MD; Susan L. Tucker, PhD; et al.
JAMA Oncol. Published online March 17, 2016. doi:10.1001/jamaoncol.2015.6478
Includes: Supplemental Content

JAMA Oncology | 
Editorial |  ONLINE FIRST
Scott F. Huntington, MD, MPH, MSHP; Cary P. Gross, MD
JAMA Oncol. Published online March 10, 2016. doi:10.1001/jamaoncol.2015.6540

JAMA | 
Viewpoint | 
Kenneth W. Lin, MD, MPH; Lawrence O. Gostin, JD
JAMA. 2016;315(10):977-978. doi:10.1001/jama.2016.0322.

JAMA Oncology | 
From The JAMA Network | 
Lesley Fallowfield, BSc, DPhil; Adele Francis, MB, ChB, FRCS, PhD
JAMA Oncol. 2016;2(3):382-383. doi:10.1001/jamaoncol.2015.5026.

JAMA Oncology | 
Original Investigation | 
Mariana Chavez-MacGregor, MD, MSc; Christina A. Clarke, PhD, MPH; Daphne Y. Lichtensztajn, MD, MPH; et al.
JAMA Oncol. 2016;2(3):322-329. doi:10.1001/jamaoncol.2015.3856.
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Invited Commentary  | 
Cardiac Protection in HER2-Targeted Treatment How Should We Measure New Strategies?
Ana Barac, MD, PhD; Sandra M. Swain, MD
JAMA Oncology
Original Investigation  | 
Angiotensin II–Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer A Randomized Clinical Trial
Annelies H. Boekhout, PhD; Jourik A. Gietema, MD, PhD; Bojana Milojkovic Kerklaan, PhD; et al.
JAMA Oncology
Review  | 
Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes A Systematic Review
Sasha E. Stanton, MD, PhD; Sylvia Adams, MD; Mary L. Disis, MD
JAMA Oncology
Original Investigation  | 
Trastuzumab-Related Cardiotoxic Effects in Taiwanese Women A Nationwide Cohort Study
Hsu-Chih Chien, MS; Yea-Huei Kao Yang, BSPharm; Jane P. F. Bai, AM, PhD